MetaCap

Aclarion (ACON) vs BioNexus Gene Lab (BGLC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Aclarion is the larger company by market cap ($3.5 million vs $2.0 million), about 1.8 times the size. BioNexus Gene Lab converts more of its revenue into profit, with a net margin of -40.2% versus -9551.9%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ACON-47.98%BGLC-49.25%
+6%-23%-52%
Oct 7, 20261 yearNov 20, 2026
ACON-47.76%BGLC-47.29%
+2%-24%-50%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ACON versus BGLC key metrics
MetricACONBGLC
Share price$1.22$0.68
Market cap$3.52M$1.99M
1-day change-13.92%0.00%
EPS (TTM)$-5.01$-1.26
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$75.73K$7.42M
Revenue growth (YoY)+65.62%-21.93%
Net income (latest FY)$-7.23M$-2.98M
Gross margin9.02%14.62%
Operating margin-9312.55%-39.93%
Net margin-9551.87%-40.20%
52-week high$9.36$4.97
52-week low$1.22$0.621
Distance from 52-week high-86.94%-86.32%
Analyst consensusstrong_buy—
Avg. price target upside+524.18%—
Average volume34.73K6.70K
Shares outstanding2.88M2.93M
Employees1019
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • BioNexus Gene Lab is more profitable, keeping -40.2 cents of every revenue dollar as net income versus -9551.9 cents for Aclarion.
  • Aclarion grew revenue faster in its latest fiscal year (+65.62% vs -21.93%).

About Aclarion

ACON stock →

Aclarion, Inc. operates as a healthcare technology company in the United States.

Health Care · Medical Specialities · 10 employees

About BioNexus Gene Lab

BGLC stock →

BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding.

Health Care · Medical Specialities · 19 employees

ACON vs BGLC FAQ

Which is bigger, Aclarion or BioNexus Gene Lab?

Aclarion (ACON) is larger, with a market capitalization of $3.52M compared with $1.99M for BioNexus Gene Lab (BGLC).

Are Aclarion and BioNexus Gene Lab in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons